Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-30

Clinical Trial Update: A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 follow-up study of rotigotine patch in adolescents with Restless Legs Syndrome was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine patch (rotigotine)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Restless Legs Syndrome | Phase 3 | Status: TERMINATED | Results posted: 2023-10-30